Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge
β Scribed by Nicola S. Gray
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 45 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.578
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed. Copyright Β© 2004 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract We report on a patient affected by Parkinson's disease who developed over a period of a few weeks a tonic deviation of her head, neck, and trunk fitting the typical description of Pisa syndrome (PS). This patient was under stable levodopa and pramipexole treatment and had never been exp